Literature DB >> 33384683

Evolution Toward Severe Covid-19 From Biological Monitoring to Therapeutic Considerations.

Julien Carvelli1,2, Audrey Le Saux1, Jeremy Bourenne1, Marc Gainnier1, Gilles Kaplanski3.   

Abstract

Entities:  

Keywords:  C reactive protein; COVID-19; IL-6; SARS-CoV-2; cytokine storm

Year:  2020        PMID： 33384683      PMCID： PMC7770161          DOI： 10.3389/fimmu.2020.562038

Source DB:  PubMed          Journal:  Front Immunol        ISSN： 1664-3224            Impact factor:   7.561


× No keyword cloud information.
  16 in total

1.  Indeed, IL-18 is more than an inducer of IFN-γ.

Authors:  Charles Anthony Dinarello; Gilles Kaplanski
Journal:  J Leukoc Biol       Date:  2018-05-07       Impact factor: 4.962

2.  COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.

Authors:  Hasan K Siddiqi; Mandeep R Mehra
Journal:  J Heart Lung Transplant       Date:  2020-03-20       Impact factor: 10.247

3.  Compassionate Use of Remdesivir for Patients with Severe Covid-19.

Authors:  Jonathan Grein; Norio Ohmagari; Daniel Shin; George Diaz; Erika Asperges; Antonella Castagna; Torsten Feldt; Gary Green; Margaret L Green; François-Xavier Lescure; Emanuele Nicastri; Rentaro Oda; Kikuo Yo; Eugenia Quiros-Roldan; Alex Studemeister; John Redinski; Seema Ahmed; Jorge Bernett; Daniel Chelliah; Danny Chen; Shingo Chihara; Stuart H Cohen; Jennifer Cunningham; Antonella D'Arminio Monforte; Saad Ismail; Hideaki Kato; Giuseppe Lapadula; Erwan L'Her; Toshitaka Maeno; Sumit Majumder; Marco Massari; Marta Mora-Rillo; Yoshikazu Mutoh; Duc Nguyen; Ewa Verweij; Alexander Zoufaly; Anu O Osinusi; Adam DeZure; Yang Zhao; Lijie Zhong; Anand Chokkalingam; Emon Elboudwarej; Laura Telep; Leighann Timbs; Ilana Henne; Scott Sellers; Huyen Cao; Susanna K Tan; Lucinda Winterbourne; Polly Desai; Robertino Mera; Anuj Gaggar; Robert P Myers; Diana M Brainard; Richard Childs; Timothy Flanigan
Journal:  N Engl J Med       Date:  2020-04-10       Impact factor: 91.245

4.  Clinical trials of disease stages in COVID 19: complicated and often misinterpreted.

Authors:  Jay J H Park; Eric H Decloedt; Craig R Rayner; Mark Cotton; Edward J Mills
Journal:  Lancet Glob Health       Date:  2020-08-20       Impact factor: 26.763

5.  Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.

Authors:  Peter Horby; Marion Mafham; Louise Linsell; Jennifer L Bell; Natalie Staplin; Jonathan R Emberson; Martin Wiselka; Andrew Ustianowski; Einas Elmahi; Benjamin Prudon; Tony Whitehouse; Timothy Felton; John Williams; Jakki Faccenda; Jonathan Underwood; J Kenneth Baillie; Lucy C Chappell; Saul N Faust; Thomas Jaki; Katie Jeffery; Wei Shen Lim; Alan Montgomery; Kathryn Rowan; Joel Tarning; James A Watson; Nicholas J White; Edmund Juszczak; Richard Haynes; Martin J Landray
Journal:  N Engl J Med       Date:  2020-10-08       Impact factor: 91.245

6.  Role of the inflammasome-related cytokines Il-1 and Il-18 during infection with murine coronavirus.

Authors:  Zachary B Zalinger; Ruth Elliott; Susan R Weiss
Journal:  J Neurovirol       Date:  2017-09-11       Impact factor: 2.643

7.  Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.

Authors:  Raphaël Cauchois; Marie Koubi; David Delarbre; Cécile Manet; Julien Carvelli; Valery Benjamin Blasco; Rodolphe Jean; Louis Fouche; Charleric Bornet; Vanessa Pauly; Karin Mazodier; Vincent Pestre; Pierre-André Jarrot; Charles A Dinarello; Gilles Kaplanski
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-22       Impact factor: 11.205

8.  Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis.

Authors:  Mathilde Roumier; Romain Paule; Alexandre Vallée; Julien Rohmer; Marie Ballester; Anne-Laure Brun; Charles Cerf; Marie-Laure Chabi; Thierry Chinet; Marie-Alice Colombier; Eric Farfour; Erwan Fourn; Guillaume Géri; David Khau; Ibrahim Marroun; Matthieu Ponsoye; Antoine Roux; Hélène Salvator; Yoland Schoindre; Anne-Gaëlle Si Larbi; Colas Tchérakian; Marc Vasse; Anne Verrat; Benjamin Zuber; Louis-Jean Couderc; Jean-Emmanuel Kahn; Matthieu Groh; Félix Ackermann
Journal:  J Clin Immunol       Date:  2020-11-14       Impact factor: 8.542

9.  Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System.

Authors:  Pascal Urwyler; Stephan Moser; Panteleimon Charitos; Ingmar A F M Heijnen; Melanie Rudin; Gregor Sommer; Bruno M Giannetti; Stefano Bassetti; Parham Sendi; Marten Trendelenburg; Michael Osthoff
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.